NCT06247501
- Conditions
- CD19 CAR-T Therapy, Very High Risk Acute Lymphoblastic Leukemia
- Locations
-
- Seoul National University Children's Hospital Seoul, South Korea
Clinical trial condition
Explore clinical trials studying Very High Risk Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.
NCT06247501